TP53 and cancer: The same alterations can be found in PDTC and ATC along with additional mutations in PI3K-AKT pathway genes and other well-established cancer-associated genes (such as TP53, TERT promoter, chromatin remodeling, and DNA damage response genes (12, 13)), in agreement with the sequential accumulation of gene alterations promoting tumor progression.